Howard W. Robin
2016
In 2016, Howard W. Robin earned a total compensation of $4.8M as President and Chief Executive Officer at Nektar Therapeutics, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $897,000 |
|---|---|
| Option Awards | $1,585,650 |
| Salary | $920,000 |
| Stock Awards | $1,346,390 |
| Other | $15,103 |
| Total | $4,764,143 |
Robin received $1.6M in option awards, accounting for 33% of the total pay in 2016.
Robin also received $897K in non-equity incentive plan, $920K in salary, $1.3M in stock awards and $15.1K in other compensation.
Rankings
In 2016, Howard W. Robin's compensation ranked 1,730th out of 14,075 executives tracked by ExecPay. In other words, Robin earned more than 87.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,730 out of 14,075 | 88th |
Division Manufacturing | 591 out of 5,489 | 89th |
Major group Chemicals And Allied Products | 165 out of 1,895 | 91st |
Industry group Drugs | 114 out of 1,538 | 93rd |
Industry Pharmaceutical Preparations | 90 out of 1,176 | 92nd |
Source: SEC filing on April 30, 2018.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2016.
2016
John Nicholson
Nektar Therapeutics
Chief Operating Officer
2016
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
2016
Stephen Doberstein
Nektar Therapeutics
Senior Vice President and Chief Research and Development Officer
2016
Maninder Hora
Nektar Therapeutics